Replies to post #186843 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Anavex could give the Japanese market to Eisai in exchange for Eisai paying for all of the FDA and EMA trial costs and Anavex getting the RoW (Rest of World) market including the USA and Europe and the rest of Asia, etc. and royalties from sales in Japan.

Alzheimer's and Dementia in Japan. In Japan more 4.6 million people are living with dementia. And this number is expected to rise significantly as the population ages.

https://www.alz.org/jp/dementia-alzheimers-japan.asp

Good luck and GOD bless,